Stockreport

Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023) [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF Net income: US$124.0k (down 99% from 1Q 2023). Profit margin: 0.1% (down from 11% in 1Q 2023). EPS: US$0.002 (down from US$0.31 in 1Q 2023). All figures shown in [Read more]